References: 1. MAXALT MIGRAINE RELIEF (rizatriptan) Product Information, April 2023. 2. MAXALT MIGRAINE RELIEF (rizatriptan) Consumer Medicine Information, April 2023. 3. HealthDirect Website. Migraine. 2021. Available at www.healthdirect.gov.au/migraine (accessed March 2024).
4. Mayo Clinic Website. Migraine. 2023. Available at www.mayoclinic.org/diseases-conditions/migraine-headache/symptoms-causes/syc-20360201 (accessed March 2024).
The MAXALT MIGRAINE RELIEF website is bought to you by Organon Pharma Pty Ltd, information displayed on this website is intended for Australian audiences only and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your healthcare professional. Please consult your healthcare professional for further information.
Copyright ©2024 Organon group of companies. All rights reserved. ORGANON, MAXALT and the ORGANON Logo are trade marks of the Organon group of companies.
Organon Pharma Pty Ltd, Level 3, Building A, 26 Talavera Rd, Macquarie Park NSW 2113 Australia. AU-MXT-110080. Date of preparation March 2024. ORMA31664W.
